Literature DB >> 19343355

Effects of UVA irradiation following treatment with 8-methoxypsoralen on type I and type III collagen synthesis in normal and scleroderma fibroblast cultures.

Yohei Kitamura1, Hiromi Namikawa, Shujiro Hayashi, Takahiro Yoshida, Toshihiro Suzuki, Yoichiro Hamasaki, Soji Yamazaki, Atsushi Hatamochi.   

Abstract

Recent studies have demonstrated the efficacy of PUVA (psoralen plus ultraviolet A irradiation) therapy against sclerotic skin lesions in scleroderma, although the mechanisms underlying the improvement of the skin sclerosis by this therapy remain unknown. We investigated the effects of ultraviolet A (UVA) irradiation following the treatment with 8-methoxypsoralen on types I and III collagen synthesis and the gene expression of collagenase in cultured normal and scleroderma fibroblasts. The treatment reduced types I and III collagen synthesis and consequently, the types I and III collagen mRNA levels, in a UVA dose-dependent manner in both the normal and SSc fibroblasts, whereas the mRNA levels of collagenase remained almost unaltered. These results suggest that reduction of collagen synthesis by the fibroblasts may be one of the mechanisms underlying the efficacy of PUVA therapy against the sclerotic skin lesions in scleroderma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19343355     DOI: 10.1007/s00403-009-0949-3

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  2 in total

1.  Successful Treatment of Scleredema Diabeticorum by Combining Local PUVA and Colchicine: A Case Report.

Authors:  Chayada Kokpol; Natta Rajatanavin; Ploysyne Rattanakemakorn
Journal:  Case Rep Dermatol       Date:  2012-09-27

2.  Effects of Xanthium stramarium and Psoralea corylifolia Extracts Combined with UVA1 Irradiation on the Cell Proliferation and TGF-β1 Expression of Keloid Fibroblasts.

Authors:  Sun Yi Park; Ji-Youn Park; Chul-Ho Kim; Sung Un Kang; Jong-Hyun Kim; Ki-Min Bark; Tae Heung Kim; Sung Chul Shin; Hee Young Kang
Journal:  Ann Dermatol       Date:  2013-08-13       Impact factor: 1.444

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.